Literature DB >> 35802259

Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specimens; prediction of lymph node metastasis in T1 colorectal cancer.

Joo Hye Song1, Yiyu Hong2, Eun Ran Kim3, Seok-Hyung Kim4, Insuk Sohn2.   

Abstract

BACKGROUND: When endoscopically resected specimens of early colorectal cancer (CRC) show high-risk features, surgery should be performed based on current guidelines because of the high-risk of lymph node metastasis (LNM). The aim of this study was to determine the utility of an artificial intelligence (AI) with deep learning (DL) of hematoxylin and eosin (H&E)-stained endoscopic resection specimens without manual-pixel-level annotation for predicting LNM in T1 CRC. In addition, we assessed AI performance for patients with only submucosal (SM) invasion depth of 1000 to 2000 μm known to be difficult to predict LNM in clinical practice.
METHODS: H&E-stained whole slide images (WSIs) were scanned for endoscopic resection specimens of 400 patients who underwent endoscopic treatment for newly diagnosed T1 CRC with additional surgery. The area under the curve (AUC) of the receiver operating characteristic curve was used to determine the accuracy of AI for predicting LNM with a fivefold cross-validation in the training set and in a held-out test set.
RESULTS: We developed an AI model using a two-step attention-based DL approach without clinical features (AUC, 0.764). Incorporating clinical features into the model did not improve its prediction accuracy for LNM. Our model reduced unnecessary additional surgery by 15.1% more than using the current guidelines (67.4% vs. 82.5%). In patients with SM invasion depth of 1000 to 2000 μm, the AI avoided 16.1% of unnecessary additional surgery than using the JSCCR guidelines.
CONCLUSIONS: Our study is the first to show that AI trained with DL of H&E-stained WSIs has the potential to predict LNM in T1 CRC using only endoscopically resected specimens with conventional histologic risk factors.
© 2022. Japanese Society of Gastroenterology.

Entities:  

Keywords:  Artificial intelligence; Lymph node metastasis; Prediction; T1 colorectal cancer; Whole slide image

Mesh:

Substances:

Year:  2022        PMID: 35802259     DOI: 10.1007/s00535-022-01894-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   6.772


  35 in total

Review 1.  Precancerous lesions of the colorectum.

Authors:  T Fujimori; H Kawamata; H Kashida
Journal:  J Gastroenterol       Date:  2001-09       Impact factor: 7.527

Review 2.  Management of malignant colon polyps: current status and controversies.

Authors:  Cary B Aarons; Skandan Shanmugan; Joshua I S Bleier
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Management of the malignant polyp.

Authors:  Marcela Ramirez; Steven Schierling; Harry T Papaconstantinou; J Scott Thomas
Journal:  Clin Colon Rectal Surg       Date:  2008-11

4.  Risk factor assessment of endoscopically removed malignant colorectal polyps.

Authors:  P Netzer; C Forster; R Biral; C Ruchti; J Neuweiler; E Stauffer; R Schönegg; C Maurer; J Hüsler; F Halter; A Schmassmann
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

5.  The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma.

Authors:  S Nivatvongs; A Rojanasakul; H M Reiman; R R Dozois; B G Wolff; J H Pemberton; R W Beart; L F Jacques
Journal:  Dis Colon Rectum       Date:  1991-04       Impact factor: 4.585

6.  Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy.

Authors:  B C Morson; J E Whiteway; E A Jones; F A Macrae; C B Williams
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

7.  Early invasive colorectal carcinomas metastatic to the lymph node with attention to their nonpolypoid development.

Authors:  T Minamoto; M Mai; T Ogino; K Sawaguchi; T Ohta; T Fujimoto; Y Takahashi
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

Review 8.  Prevalence and risk factors of colorectal cancer in Asia.

Authors:  Martin Cs Wong; Hanyue Ding; Jingxuan Wang; Paul Sf Chan; Junjie Huang
Journal:  Intest Res       Date:  2019-05-20

9.  Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels.

Authors:  Irene Pérez; Lidia Fernández; Silvia Sánchez-Ramón; Cristina Alba; Ana Zatarain; Mercedes Cañas; Olga N López; David Olivares; Enrique Rey; Carlos Taxonera
Journal:  Therap Adv Gastroenterol       Date:  2018-06-26       Impact factor: 4.409

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more
  1 in total

1.  "Pathologist-independent" strategy for T1 colorectal cancer after endoscopic resection.

Authors:  Katsuro Ichimasa; Shin-Ei Kudo; Jonathan Wei Jie Lee; Khay Guan Yeoh
Journal:  J Gastroenterol       Date:  2022-08-12       Impact factor: 6.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.